These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 27044275

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.
    Yang Y, Zhang YJ, Zhu Y, Cao JZ, Yuan ZY, Xu LM, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, Liu QF, Li YX.
    Leukemia; 2015 Jul; 29(7):1571-7. PubMed ID: 25697894
    [Abstract] [Full Text] [Related]

  • 5. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L, Wang Z, Xia ZJ, Lu Y, Huang HQ, Zhang YJ.
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [Abstract] [Full Text] [Related]

  • 6. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage IE /IIE extranodal natural killer/T-cell lymphoma.
    Wang HY, Niu SQ, Yang YY, Li YY, Chen HB, Zhang YJ.
    Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
    Liu WX, Liu YP, Jin J, Wang SL, Fang H, Ren H, Song YW, Chen B, Lu NN, Li N, Tang Y, Qi SN, Tang Y, Wang WH, Li YX.
    Zhonghua Zhong Liu Za Zhi; 2019 Jan 23; 41(1):56-62. PubMed ID: 30678418
    [Abstract] [Full Text] [Related]

  • 9. Patterns of Primary Tumor Invasion and Regional Lymph Node Spread Based on Magnetic Resonance Imaging in Early-Stage Nasal NK/T-cell Lymphoma: Implications for Clinical Target Volume Definition and Prognostic Significance.
    Wu RY, Liu K, Wang WH, Jin J, Song YW, Wang SL, Liu YP, Ren H, Fang H, Liu QF, Yang Y, Chen B, Qi SN, Lu NN, Tang Y, Tang Y, Li N, Ouyang H, Li YX.
    Int J Radiat Oncol Biol Phys; 2017 Jan 01; 97(1):50-59. PubMed ID: 27816363
    [Abstract] [Full Text] [Related]

  • 10. The extent of local tumor invasion predicts prognosis in stage IE nasal natural killer/T-cell lymphoma: a novel T staging system for risk stratification.
    Bi XW, Zhang WW, Li ZM, Huang JJ, Xia Y, Sun P, Wang Y, Jiang WQ.
    Ann Hematol; 2015 Sep 01; 94(9):1515-24. PubMed ID: 25924921
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer/T cell lymphoma, nasal type.
    Wang L, Xia ZJ, Lu Y, Zhang YJ.
    Med Oncol; 2015 Jan 01; 32(1):320. PubMed ID: 25429828
    [Abstract] [Full Text] [Related]

  • 12. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
    Zeng L, Huang W, Cao Z, Zheng B, Liu X, Guo L, Feng X.
    Ann Hematol; 2019 Jun 01; 98(6):1467-1476. PubMed ID: 30895352
    [Abstract] [Full Text] [Related]

  • 13. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
    Kim SJ, Oh SY, Hong JY, Chang MH, Lee DH, Huh J, Ko YH, Ahn YC, Kim HJ, Suh C, Kim K, Kim WS.
    Ann Oncol; 2010 May 01; 21(5):1058-63. PubMed ID: 19850636
    [Abstract] [Full Text] [Related]

  • 14. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
    Wang KF, Chang BY, Chen XQ, Liu PP, Wuxiao ZJ, Wang ZH, Li S, Jiang WQ, Xia ZJ.
    Med Oncol; 2014 Dec 01; 31(12):318. PubMed ID: 25377661
    [Abstract] [Full Text] [Related]

  • 15. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.
    Oral Oncol; 2008 Jan 01; 44(1):23-30. PubMed ID: 17306611
    [Abstract] [Full Text] [Related]

  • 16. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
    Dai W, Jia B, Yang J, Zhou S, Liu P, He X, Qin Y, Gui L, Zhang C, Han X, Sun Y, Shi Y.
    Oncotarget; 2017 May 23; 8(21):34787-34795. PubMed ID: 28410236
    [Abstract] [Full Text] [Related]

  • 17. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF, Wang WH, Wang SL, Liu YP, Huang WT, Lu N, Zhou LQ, Ouyang H, Jin J, Li YX.
    Int J Radiat Oncol Biol Phys; 2014 Mar 15; 88(4):806-13. PubMed ID: 24495590
    [Abstract] [Full Text] [Related]

  • 18. MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.
    Gu Y, Wu B, Zhang Y, Guo Y, Peng W.
    Eur Rev Med Pharmacol Sci; 2014 Mar 15; 18(3):404-12. PubMed ID: 24563442
    [Abstract] [Full Text] [Related]

  • 19. Short-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
    Li J, Li Y, Zhong M, Liu X, Song Y, Li J, Li K, Yi P.
    Med Sci Monit; 2018 May 01; 24():2683-2692. PubMed ID: 29712887
    [Abstract] [Full Text] [Related]

  • 20. [Extranodal NK/T-cell lymphoma, nasal type: a clinical analysis].
    Chen F, Shen CX, Wang HG, Li GX, Wang XQ, Wen Z.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar 05; 31(5):327-333. PubMed ID: 29871255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.